Table 2.
The 15 most discriminative features (with the largest importance scores)
| Parameter | Importance score | Spearman’s (r) | p-value |
|---|---|---|---|
| Hypercholesterolemia | 15.96 | 0.38 | < 0.0001 |
| Plaque score L | 12.68 | 0.41 | < 0.0001 |
| Plaque score R | 10.94 | 0.38 | < 0.0001 |
| Duration of T2DM | 10.65 | 0.32 | < 0.0001 |
| Plaque area R | 10.00 | 0.34 | < 0.0001 |
| Age | 8.60 | 0.37 | < 0.0001 |
| Plaque area L | 8.36 | 0.35 | < 0.0001 |
| Betabloker | 7.66 | 0.25 | 0.0004 |
| T2DM | 7.08 | 0.24 | 0.0008 |
| Hypertension | 6.83 | 0.24 | 0.0010 |
| cfPWV | 6.64 | 0.28 | < 0.0001 |
| ALT | 4.69 | –0.15 | 0.0329 |
| eGFR | 3.51 | –0.28 | < 0.0001 |
| HbA1c | 3.19 | 0.22 | 0.0025 |
| Obesity | 3.17 | –0.15 | 0.0421 |
We report the two-tailed p-values for nonparametric Spearman correlation to verify if the correlation is due to random sampling (if p < 0.05 this hypothesis can be rejected)
T2DM type 2 diabetes mellitus, cfPWV carotid-femoral pulse wave velocity, ALT alanine aminotransferase, eGFR estimated glomerular filtration rate, HbA1c hemoglobin A1c